Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-08

Clinical Trial Update: A Comparison of Prophylactic Antibacterial Efficacy of Besivance vs. VIGAMOX Prior to Cataract Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial comparing prophylactic antibacterial efficacy of Besivance versus VIGAMOX before cataract surgery; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BESIVANCE (besifloxacin)
  • VIGAMOX (Moxifloxacin hydrochloride)

Snippet

Sponsor: Bucci Laser Vision Institute | Conditions: Cataracts | Phase 4 | Status: COMPLETED | Results posted: 2020-12-08